FluoTag®-Q anti-SARS-CoV-2 Spike protein S1

Cat No: N3501 Category:

375,00 

The FluoTag-Q anti-SARS-CoV-2 S1 is based on the W25 clone, which has a sub-nanomolar affinity for the SARS-CoV-2 S1 protein receptor binding domain (RBD) and can neutralize infections as it efficiently competes with ACE-2 receptor binding.

Read more

Clear

This anti-Sars-CoV-2 Spike protein S1 nanobody was developed by the team of Alejandro Rojas-Fernandez at the Institute of Medicine at the Universidad Austral de Chile. We acquired the exclusive license to produce this nanobody and make it available for research and development purposes. The FluoTag-Q anti-SARS-CoV-2 S1 is based on the W25 clone, which has a sub-nanomolar affinity for the SARS-CoV-2 S1 protein receptor binding domain (RBD) and can neutralize infections as it efficiently competes with ACE-2 receptor binding.

For detailed information regarding our FluoTag-Q, -X2 and -X4 series check our technology section here.

MSDS
Variations:
Conjugation Amount Cat No.
AbberiorStar580 200 μl N3501-Ab580-L
AbberiorStar635P 200 μl N3501-Ab635P-L
Alexa647 200 μl N3501-AF647-L
Atto488 200 μl N3501-At488-L
AZDye568 200 μl N3501-AF568-L
Related Products: -
Clone: W25
Host: Alpaca
Produced in: E.coli
Application: IF
Dilution: 1:500
Capacity: N/A
Antigen: SARS-CoV-2 S1
Specificity: Recognizes the RBD of the SARS-CoV-2 S1 protein.
Formulation: Lyophilized from PBS pH 7.4. Reconstitute with 200 µL 50 % glycerol including 0.1 % sodium azid as preservative if applicable.
kDa: -
Ext Coef: -
Shipping: Ambient temperature
Storing: Vials containing lyophilized protein can be stored at 4 °C for 6 months. We recommend reconstituting the protein with 50 % sterile glycerol including 0.1 % sodium azide as preservative if applicable. Minimize the number of freeze-thaw cycles by aliquoting the reconstituted protein. Long term storage at -80 °C for up to 6 months. Working aliquots can be stored at -20 °C for up to 4 weeks. We do not recommend storing the reconstituted protein at 4 °C.
Protocols: -
References:

Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity Nanobody
doi: https://doi.org/10.1101/2020.06.09.137935

Notice: To be used in vitro/ for research only. Non-toxic, non-hazardous, non-infectious.
Legal terms: By purchasing this product you agree to our general terms and conditions.